Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108017
Status:
COMPLETED
Last Update Posted:
2015-05-13
First Post:
2005-04-12
Brief Title:
Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours 0507A-137COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
Randomized Multicenter Dbl-Masked Parallel Study Evaluating the 24 Hr Diurnal Ocular Hypotensive Effect of 2 Dorzolamide Hydrochloride05 Timolol Maleate Combo Ophthalmic Sol in Patients w Open Angle Glaucoma or Ocular Hypertension
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_021 | None | None | None |